关注
Narges Cheshmazar
Narges Cheshmazar
Ph.D. in Medicinal Chemistry, Tabriz University of Medical Science, Biotechnology Research Center
在 tbzmed.ac.ir 的电子邮件经过验证
标题
引用次数
引用次数
年份
Current trends in development of HDAC-based chemotherapeutics
N Cheshmazar, M Hamzeh-Mivehroud, HN Charoudeh, S Hemmati, ...
Life Sciences 308, 120946, 2022
272022
Aldehyde oxidase at the crossroad of metabolism and preclinical screening
N Cheshmazar, S Dastmalchi, M Terao, E Garattini, ...
Drug metabolism reviews 51 (4), 428-452, 2019
172019
Development of New Inhibitors of HDAC1–3 Enzymes Aided by In Silico Design Strategies
N Cheshmazar, S Hemmati, M Hamzeh-Mivehroud, B Sokouti, M Zessin, ...
Journal of Chemical Information and Modeling 62 (10), 2387-2397, 2022
82022
Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluation
N Cheshmazar, M Hamzeh-Mivehroud, S Hemmati, H Abolhasani, ...
Future Medicinal Chemistry, 2024
2024
Rational design, synthesis, biological evaluation and molecular modeling of histone deacetylase inhibitors as anti-breast cancer stem cell agents
N Cheshmazar
Tabriz University of Medical Sciences, School of Pharmacy, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–5